Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
5,755
-1,258
-18% -$431K 0.06% 247
2026
Q1
$2.47M Sell
7,013
-1,074
-13% -$383K 0.08% 204
2025
Q4
$2.65M Sell
8,087
-7
-0.1% -$2.22K 0.09% 196
2025
Q3
$2.28M Sell
8,094
-2,867
-26% -$831K 0.08% 214
2025
Q2
$3.06M Buy
10,961
+531
+5% +$150K 0.12% 157
2025
Q1
$3.25M Sell
10,430
-1,962
-16% -$579K 0.14% 136
2024
Q4
$3.23M Buy
12,392
+3,659
+42% +$1.09M 0.15% 136
2024
Q3
$2.81M Buy
+8,733
New +$2.86M 0.13% 160
2024
Q2
Sell
-11,436
Closed -$3.25M 1641
2024
Q1
$3.25M Sell
11,436
-2,020
-15% -$591K 0.17% 120
2023
Q4
$3.88M Buy
13,456
+8,231
+158% +$2.24M 0.25% 81
2023
Q3
$1.4M Buy
5,225
+469
+10% +$117K 0.1% 191
2023
Q2
$1.06M Buy
+4,756
New +$1.1M 0.08% 238
2022
Q4
$2.68M Sell
10,193
-5,852
-36% -$1.57M 0.19% 92
2022
Q3
$3.62M Buy
16,045
+727
+5% +$176K 0.3% 62
2022
Q2
$3.73M Buy
15,318
+10,447
+214% +$2.56M 0.29% 63
2022
Q1
$1.18M Sell
4,871
-367
-7% -$84.3K 0.08% 193
2021
Q4
$1.18M Buy
+5,238
New +$1.11M 0.08% 207

Other funds holding AMGN

CoreCap Advisors's AMGN Position: Q2 2026 in Review

CoreCap Advisors reduced its Amgen (AMGN) stake by 18% in Q2 2026, selling an estimated $431K and leaving 5,755 shares worth $2.08M. The position accounts for 0.06% of the portfolio, ranked #247.

CoreCap Advisors first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.88M in Q4 2023. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CoreCap Advisors held 5,755 shares of Amgen worth $2.08M as of Q2 2026.
  • CoreCap Advisors sold 1,258 Amgen shares in Q2 2026, an estimated $431K.
  • Amgen made up 0.06% of CoreCap Advisors's portfolio in Q2 2026, its #247 holding.
  • CoreCap Advisors first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
  • CoreCap Advisors's Amgen position peaked at $3.88M in Q4 2023.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.